P0C6X6 (R1AB_CVHOC) Human coronavirus OC43 (HCoV-OC43)
Replicase polyprotein 1ab UniProtKBInterProInteractive Modelling
7095 aa; Sequence (Fasta)
Molecule Processing
| Host translation inhibitor nsp1 | |
| Non-structural protein 2 | |
| Papain-like proteinase | |
| Non-structural protein 4 | |
| 3C-like proteinase | |
| Non-structural protein 6 | |
| Non-structural protein 7 | |
| Non-structural protein 8 | |
| Non-structural protein 9 | |
| Non-structural protein 10 | |
| RNA-directed RNA polymerase | |
| Helicase | |
| Guanine-N7 methyltransferase | |
| Uridylate-specific endoribonuclease | |
| 2'-O-methyltransferase |
It is possible new templates exist for this target since these models were created.
Sequence Features
| 1074 | For PL1-PRO activity | ||
| 1225 | For PL1-PRO activity | ||
| 1671 | For PL2-PRO activity | ||
| 1828 | For PL2-PRO activity | ||
| 3287 | For 3CL-PRO activity | ||
| 3391 | For 3CL-PRO activity | ||
| 5302 | Zinc 1 | ||
| 5305 | Zinc 1 | ||
| 5313 | Zinc 2 | ||
| 5316 | Zinc 1 | ||
| 5323 | Zinc 1 | ||
| 5326 | Zinc 2 | ||
| 5330 | Zinc 2 | ||
| 5336 | Zinc 2 | ||
| 5347 | Zinc 3 | ||
| 5352 | Zinc 3 | ||
| 5369 | Zinc 3 | ||
| 5372 | Zinc 3 | ||
| 88 | H -> D (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 207 | C -> R (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 291 | P -> L (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 317 | C -> R (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 356 | F -> V (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 545 | I -> L (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 762 | D -> N (in strain: Isolate 87309 Belgium 2003) | ||
| 953 | F -> L (in strain: ATCC VR-759, Isolate clinical OC43-Paris and Isolate 87309 Belgium 2003) | ||
| 989 | I -> V (in strain: ATCC VR-759, Isolate clinical OC43-Paris and Isolate 87309 Belgium 2003) | ||
| 1305 | V -> A (in strain: ATCC VR-759, Isolate clinical OC43-Paris and Isolate 87309 Belgium 2003) | ||
| 1328 | N -> D (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 1379 | F -> L (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 1504 | L -> V (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 1740 | G -> E (in strain: Isolate 87309 Belgium 2003) | ||
| 1825 | N -> K (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 1936 | S -> A (in strain: ATCC VR-759, Isolate clinical OC43-Paris and Isolate 87309 Belgium 2003) | ||
| 1965 | N -> T (in strain: ATCC VR-759, Isolate clinical OC43-Paris) | ||
| 2004 | L -> S (in strain: ATCC VR-759, Isolate clinical OC43-Paris and Isolate 87309 Belgium 2003) | ||
| 2022 | S -> G (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 2256 | I -> M (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 2257 | Q -> H (in strain: Isolate 87309 Belgium 2003) | ||
| 2386 | K -> R (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 2500 | I -> T (in strain: ATCC VR-759, Isolate clinical OC43-Paris and Isolate 87309 Belgium 2003) | ||
| 2921 | D -> E (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 2961 | V -> I (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 3086 | T -> I (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 3440 | P -> L (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 3451 | L -> V (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 3466 | I -> V (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 4067 | I -> V (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 4071 | I -> V (in strain: ATCC VR-759, Isolate clinical OC43-Paris and Isolate 87309 Belgium 2003) | ||
| 4382 | A -> T (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 4994 | I -> L (in strain: ATCC VR-759, Isolate clinical OC43-Paris and Isolate Tulsa 1999 and Isolate 87309 Belgium 2003) | ||
| 5765 | L -> S (in strain: ATCC VR-759, Isolate clinical OC43-Paris and Isolate 87309 Belgium 2003) | ||
| 5997 | L -> R (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 6236 | G -> A (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 6454 | T -> A (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 6546 | F -> L (in strain: ATCC VR-759, Isolate clinical OC43-Paris and Isolate 87309 Belgium 2003) | ||
| 6636 | D -> E (in strain: Isolate 87309 Belgium 2003) | ||
| 6665 | A -> T (in strain: Isolate 87309 Belgium 2003) | ||
| 6754 | T -> A (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 2138-2158 | Helical | ||
| 2199-2219 | Helical | ||
| 2221-2241 | Helical | ||
| 2313-2333 | Helical | ||
| 2343-2363 | Helical | ||
| 2365-2385 | Helical | ||
| 2752-2772 | Helical | ||
| 2824-2844 | Helical | ||
| 3009-3029 | Helical | ||
| 3031-3051 | Helical | ||
| 3063-3083 | Helical | ||
| 3090-3110 | Helical | ||
| 3115-3135 | Helical | ||
| 3558-3578 | Helical | ||
| 3588-3608 | Helical | ||
| 3615-3635 | Helical | ||
| 3657-3677 | Helical | ||
| 3684-3704 | Helical | ||
| 3711-3731 | Helical | ||
| 3755-3775 | Helical | ||
| 1151-1179 | C4-type 1 | ||
| 1749-1785 | C4-type 2 | ||
| 4306-4322 | |||
| 4348-4361 | |||
| 5578-5585 | ATP | ||
| 246-247 | Cleavage; by PL1-PRO | ||
| 851-852 | Cleavage; by PL1-PRO | ||
| 2750-2751 | Cleavage; by PL2-PRO | ||
| 3246-3247 | Cleavage; by 3CL-PRO | ||
| 3549-3550 | Cleavage; by 3CL-PRO | ||
| 3836-3837 | Cleavage; by 3CL-PRO | ||
| 3925-3926 | Cleavage; by 3CL-PRO | ||
| 4122-4123 | Cleavage; by 3CL-PRO | ||
| 4232-4233 | Cleavage; by 3CL-PRO | ||
| 4369-4370 | Cleavage; by 3CL-PRO | ||
| 5297-5298 | Cleavage; by 3CL-PRO | ||
| 5900-5901 | Cleavage; by 3CL-PRO | ||
| 6421-6422 | Cleavage; by 3CL-PRO | ||
| 6796-6797 | Cleavage; by 3CL-PRO | ||
| 2138-2140 | TSA -> ISV (in strain: ATCC VR-759 and Isolate clinical OC43-Paris) | ||
| 5014-5015 | SD -> RT (in strain: Isolate Tulsa 1999) | ||
| 1-353 | Betacoronavirus NSP1 IPR022570PF11963 | ||
| 678-850 | Non-structural protein 2, C-terminal domain, coronavirus IPR043613PF19212 | ||
| 1055-1285 | Peptidase C30/C16, Betacoronavirus IPR002705PF01831 | ||
| 1297-1401 | Macro domain IPR002589PF01661 | ||
| 1565-1866 | Peptidase C16, coronavirus IPR013016PF08715 | ||
| 1900-2016 | Non-structural protein NSP3, nucleic acid-binding (NAR) domain, betacoronavirus IPR032592PF16251 | ||
| 2250-2735 | Coronavirus replicase NSP3, C-terminal IPR043611PF19218 | ||
| 2772-3128 | Coronavirus replicase NSP4, N-terminal IPR043612PF19217 | ||
| 3153-3244 | Non-structural protein NSP4, C-terminal, coronavirus IPR032505PF16348 | ||
| 3275-3562 | Peptidase C30, coronavirus IPR008740PF05409 | ||
| 3577-3836 | Non-structural protein 6, coronavirus IPR043610PF19213 | ||
| 3837-3925 | Non-structural protein NSP7, coronavirus IPR014828PF08716 | ||
| 3926-4116 | Non-structural protein NSP8, coronavirus-like IPR014829PF08717 | ||
| 4123-4232 | Non-structural protein NSP9, coronavirus IPR014822PF08710 | ||
| 4241-4361 | RNA synthesis protein NSP10, coronavirus IPR018995PF09401 | ||
| 4383-4731 | RNA polymerase, N-terminal, coronaviral IPR009469PF06478 | ||
| 4764-5254 | RNA-directed RNA polymerase, C-terminal domain IPR001205PF00680 | ||
| 5729-5871 | DNA2/NAM7 helicase-like, C-terminal IPR041679PF13087 | ||
| 5902-6419 | Non-structural protein 14, coronavirus IPR009466PF06471 | ||
| 6422-6482 | Coronavirus replicase NSP15, N-terminal oligomerisation IPR043606PF19219 | ||
| 6492-6583 | Coronavirus replicase NSP15, middle domain IPR043608PF19216 | ||
| 6642-6794 | NendoU domain, nidovirus IPR043609PF19215 | ||
| 6799-7094 | Non-structural protein NSP16, coronavirus-like IPR009461PF06460 |
Sequence Alignments
Papain-like proteinase 852-2750; PRO_0000283828
| Oligo-state | Ligands | QMEAN | Template | Range | Seq id (%) |
|---|---|---|---|---|---|
| monomer | 1×ZN; | -0.77 | 4ypt.1.A | 64.08 | |
| Assess | |||||
3C-like proteinase 3247-3549; PRO_0000283830
| Oligo-state | Ligands | QMEAN | Template | Range | Seq id (%) |
|---|---|---|---|---|---|
| monomer | 1×02J; | -1.44 | 6jij.1.A | 83.06 | |
| Assess | |||||
RNA-directed RNA polymerase 4370-5297; PRO_0000037308
| Oligo-state | Ligands | QMEAN | Template | Range | Seq id (%) |
|---|---|---|---|---|---|
| monomer | 2×ZN; | -1.98 | 7c2k.1.A | 66.56 | |
| Assess | |||||
Uridylate-specific endoribonuclease 6422-6796; PRO_0000283838
| Oligo-state | Ligands | QMEAN | Template | Range | Seq id (%) |
|---|---|---|---|---|---|
| monomer | -2.36 | 2gti.1.A | 75.34 | ||
| Assess | |||||